# HPV-based cervical cancer screening in three Nicaraguan provinces: from testing to treatment

Source: https://onco.cc/key-papers/paper-holme-hpv-screening-nicaragua-bmcph-2020/  
OnCo record `paper-holme-hpv-screening-nicaragua-bmcph-2020` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

HPV testing, mostly on samples women collected themselves, was introduced in three Nicaraguan provinces between 2014 and 2018; in 2017, 44,635 women were screened and 15.2% tested positive, and the authors estimated an overall treatment percentage of 27.8% against WHO's goal of 90%.

## Summary

Published as "HPV-based cervical cancer screening in Nicaragua: from testing to treatment". The authors analysed individual-level data from routinely collected forms for women attending HPV-based screening, which was introduced between 2014 and 2018 in three provinces (Carazo, Chinandega and Chontales); the open full text says the analysis covers screening in 2017. Women who tested positive were triaged with a Pap test or visual inspection with acetic acid before treatment.

## Fields

- Kind: Key paper
- Last checked: 2026-11-16
- Journal: BMC Public Health
- Year: 2020
- DOI: 10.1186/s12889-020-08601-z
- Authors: Holme F, Maldonado F, Martinez-Granera OB, et al.
- Findings: 44,635 women were screened with HPV testing in 2017, 96.6% of them by self-sampling; 6,776 (15.2%) were HPV positive.; 54.0% of screen-positive women received triage and 53.1% of triage-positive women were treated, primarily with cryotherapy; applying the same triage-positive rate to the women lost at triage, the authors put the overall treatment percentage at 27.8%, an estimate that assumes those women were not treated elsewhere.; The odds of receiving treatment after Pap triage were far lower than after visual inspection (adjusted odds ratio 0.05, 95% CI 0.04 to 0.08).
- What it means: Reaching women with an HPV test worked and self-sampling was widely accepted; the step that lost most women was the follow-up of a positive result, particularly where the follow-up test was a Pap smear.
- Caveats: Three provinces, not the whole country, and one year of screening (2017).; Programme data from routine forms.; The 27.8% is the authors' estimate, not a count of women treated.

## Sources

- BMC Public Health 2020: https://doi.org/10.1186/s12889-020-08601-z
- PubMed: https://pubmed.ncbi.nlm.nih.gov/32295562/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- institutions: [Ministerio de Salud de Nicaragua (MINSA)](https://onco.cc/institutions/minsa-nicaragua/)

---
JSON: https://onco.cc/api/v1/entities/paper-holme-hpv-screening-nicaragua-bmcph-2020.json